Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
214,467,875
-
Total 13F shares
-
21,056,974
-
Share change
-
-949,081
-
Total reported value
-
$197,303,107
-
Put/Call ratio
-
0%
-
Price per share
-
$9.37
-
Number of holders
-
71
-
Value change
-
-$18,088,390
-
Number of buys
-
40
-
Number of sells
-
34
Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q4 2015
As of 31 Dec 2015,
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,056,974 shares.
The largest 10 holders included
FMR LLC, Capital Research Global Investors, Versant Venture Management, LLC, Capital World Investors, SV Life Sciences Advisers, LLC, FEDERATED INVESTORS INC /PA/, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, and JENNISON ASSOCIATES LLC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.